![Table 1 from Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. | Semantic Scholar Table 1 from Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9e7d629a805f5990afc5283811da0e01a231af15/51-Table1-1.png)
Table 1 from Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. | Semantic Scholar
![The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility? | Thorax The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility? | Thorax](https://thorax.bmj.com/content/thoraxjnl/68/2/195/F1.large.jpg)
The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility? | Thorax
![Beta-2 agonists mnemonic ... #Salmeterol #Formoterol | Pharmacology nursing, Education help, Pharmacology Beta-2 agonists mnemonic ... #Salmeterol #Formoterol | Pharmacology nursing, Education help, Pharmacology](https://i.pinimg.com/originals/ff/40/91/ff409160a6bcf547dac5505fcd3e5373.jpg)
Beta-2 agonists mnemonic ... #Salmeterol #Formoterol | Pharmacology nursing, Education help, Pharmacology
![Table 2 from Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | Semantic Scholar Table 2 from Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2efa96cf6b57178b8ed6a0ce30e70c7c1bfcc2b6/96-Table2-1.png)
Table 2 from Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. | Semantic Scholar
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice? Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?](https://www.researchpad.co/dataresources/articles/985/31539/assets/bmjresp-2020-000840f01.jpg)
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?
![Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/2101606933/2080045921/gr1.jpg)
Debate on long-acting β agonists for asthma: they think it's all over - The Lancet Respiratory Medicine
![Adding a long-acting beta2-agonist (LABA) to asthma treatment for adults - Best Practice Advocacy Centre New Zealand Adding a long-acting beta2-agonist (LABA) to asthma treatment for adults - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/laba-main.jpg)
Adding a long-acting beta2-agonist (LABA) to asthma treatment for adults - Best Practice Advocacy Centre New Zealand
![Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents | Respiratory Research | Full Text Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1465-9921-11-149/MediaObjects/12931_2010_992_Fig1_HTML.jpg)
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents | Respiratory Research | Full Text
![Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD). - ppt download Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD). - ppt download](https://images.slideplayer.com/32/10015656/slides/slide_20.jpg)